• An Aussie medtech company is leading the charge in home-testing for COVID-19, but legislation means Aussies — and the small businesses that employ them — are not able to reap the benefits.

  That’s according to Dr Sean Parsons, founder and chief of medtech Ellume, which has developed a COVID-19 home testing kit already in use in the US.

  In an interview with the Australian Financial Review, Parsons suggested home testing for the virus should play a key role in returning to some kind of normality — that is, reopening borders and avoiding further lockdown situations.

  ” target=”_blank”>

• The founder of an Australian firm which produces at-home COVID-19 testing kits says the federal government appears “unwilling” to consider testing alternatives.
• Ellume founder Sean Parsons told “Sunrise” the kits, which have been approved for use in the U.S., could be helpful during lockdowns to reduce long queues for traditional testing centres.
• Therapeutic goods legislation currently bars home COVID-19 tests from being sold or advertised in Australia, with the nation’s drug watchdog citing fears over faulty test results.
• Visit Business Insider Australia’s homepage for more stories.

An Australian-based manufacturer of rapid COVID-19 tests says the federal government appears “unwilling” to consider its products for home use, after the United States’ drug watchdog approved the products for use in both domestic and clinical settings.

• May 10, 2021

  An Australian company that recently began selling a rapid at-home COVID-19 test plans to open its first U.S. production plant in Maryland later this year.

  Ellume plans to announce today that it will make the test kits in Ballenger Creek, just south of Frederick, and eventually employ 1,500 people to make up to 19 million test kits a month.

  ” target=”_blank”>